Please enable JavaScript to continue using this application.

Compare $KLRA vs $STOK | Chartloom

Compare

$KLRA vs $STOK

Kailera Therapeutics Inc · Stoke Therapeutics Inc

KLRA

Kailera Therapeutics Inc

STOK

Stoke Therapeutics Inc

Compare $KLRA vs $STOK

Comparing Kailera Therapeutics Inc and Stoke Therapeutics Inc

KLRAKailera Therapeutics Inc

STOKStoke Therapeutics Inc

KLRAKailera Therapeutics Inc

Market cap

$1.50B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-55.3%

52W performance

-55.3%

FCF yield

0.0%

STOKStoke Therapeutics Inc

Market cap

$1.54B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

47.27x

Rev growth (TTM)

-86.2%

YTD performance

-19.9%

52W performance

-18.9%

FCF yield

-11.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KLRA

STOK

Detailed metrics comparison

KLRA

Kailera Therapeutics Inc

STOK

Stoke Therapeutics Inc

Market Cap

KLRA$1.50B

STOK$1.54B

Enterprise Value

KLRA$1.37B

STOK$1.43B

Price

KLRA$11.61

STOK$24.74

P/E Ratio

KLRAN/A

STOKN/A

P/S Ratio

KLRA0.00x

STOK55.85x

EV/Sales

KLRA0.00x

STOK51.86x

EV/EBITDA

KLRA0.00x

STOK53.69x

P/B Ratio

KLRA1.20x

STOK4.78x

P/FCF Ratio

KLRAN/A

STOKN/A

EV/FCF

KLRA0.00x

STOK-7.92x

PEG Ratio

KLRAN/A

STOKN/A

Forward P/E (NTM)

KLRAN/A

STOKN/A

Forward P/S (NTM)

KLRAN/A

STOK47.27x

Revenue (TTM)

KLRA$0

STOK$28M

Revenue Growth (YoY)

KLRAN/A

STOK-86.2%

Forward Rev Growth

KLRA275.8%

STOK62.9%

Gross Margin (TTM)

KLRA0.0%

STOK0.0%

Operating Margin (TTM)

KLRA0.0%

STOK0.0%

EBITDA Margin (TTM)

KLRA0.0%

STOK-803.4%

Net Margin (TTM)

KLRA0.0%

STOK-753.6%

FCF Margin (TTM)

KLRAN/A

STOK-654.9%

Net Income (TTM)

KLRA$-190M

STOK$-208M

FCF (TTM)

KLRA$0

STOK$-181M

EPS (TTM)

KLRA-$1.86

STOK-$3.15

ROE (TTM)

KLRA0.0%

STOK-5936.0%

ROA (TTM)

KLRA0.0%

STOK-5146.0%

ROIC (TTM)

KLRA0.0%

STOK-5936.0%

Cash

KLRA$130M

STOK$110M

Debt

KLRA$0

STOK$0

Net Cash/Debt

KLRA$130M

STOK$110M

Current Ratio (TTM)

KLRA11.11x

STOK7.69x

Quick Ratio (TTM)

KLRA11.04x

STOK7.34x

Debt/Equity (TTM)

KLRA0.00x

STOK0.00x

Debt/Assets (TTM)

KLRA0.0%

STOK0.0%

Interest Coverage (TTM)

KLRAN/A

STOKN/A

Net Debt/EBITDA (TTM)

KLRA0.00x

STOK0.00x

Beta

KLRA2.22

STOK1.36

52W Performance

KLRA-55.3%

STOK-18.9%

YTD Performance

KLRA-55.3%

STOK-19.9%

% from 52W High

KLRA-58.9%

STOK-38.5%

% from 52W Low

KLRA19.0%

STOK21.8%

Asset Turnover (TTM)

KLRA0.00x

STOK0.07x

FCF Yield (TTM)

KLRA0.0%

STOK-11.7%

Earnings Yield (TTM)

KLRA-12.6%

STOK-13.5%

Dividend Yield (TTM)

KLRAN/A

STOKN/A

Rule of 40

KLRA0.0

STOK-741.1

EV/GP/RG

KLRAN/A

STOKN/A

Ticker research

View KLRA research View STOK research

Metric	KLRA Kailera Therapeutics Inc	STOK Stoke Therapeutics Inc
Market & Valuation
Market Cap	$1.50B	$1.54B
Enterprise Value	$1.37B	$1.43B
Price	$11.61	$24.74
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	55.85x
EV/Sales	0.00x	51.86x
EV/EBITDA	0.00x	53.69x
P/B Ratio	1.20x	4.78x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-7.92x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	47.27x
Revenue & Growth
Revenue (TTM)	$0	$28M
Revenue Growth (YoY)	N/A	-86.2%
Forward Rev Growth	275.8%	62.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-803.4%
Net Margin (TTM)	0.0%	-753.6%
FCF Margin (TTM)	N/A	-654.9%
Net Income (TTM)	$-190M	$-208M
FCF (TTM)	$0	$-181M
EPS (TTM)	-$1.86	-$3.15
ROE (TTM)	0.0%	-5936.0%
ROA (TTM)	0.0%	-5146.0%
ROIC (TTM)	0.0%	-5936.0%
Financial Health
Cash	$130M	$110M
Debt	$0	$0
Net Cash/Debt	$130M	$110M
Current Ratio (TTM)	11.11x	7.69x
Quick Ratio (TTM)	11.04x	7.34x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.22	1.36
52W Performance	-55.3%	-18.9%
YTD Performance	-55.3%	-19.9%
% from 52W High	-58.9%	-38.5%
% from 52W Low	19.0%	21.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.07x
FCF Yield (TTM)	0.0%	-11.7%
Earnings Yield (TTM)	-12.6%	-13.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-741.1
EV/GP/RG	N/A	N/A
Ticker research	View KLRA research	View STOK research

Valuation

P/S Ratio

KLRA

0.00x

STOK

55.85x

EV/FCF

STOK

-7.92x

KLRA

0.00x

Growth & revenue

Revenue Growth TTM

STOK

-86.2%

Forward Revenue Growth

KLRA

275.8%

STOK

62.9%

Profitability & performance

Gross Margin

KLRA

0.0%

STOK

0.0%

ROE

KLRA

0.0%

STOK

-5936.0%

FCF Yield %

KLRA

0.0%

STOK

-11.7%

52-Week Performance

STOK

-18.9%

KLRA

-55.3%

Detailed metrics comparison

KLRA

Kailera Therapeutics Inc

STOK

Stoke Therapeutics Inc

Market Cap

KLRA$1.50B

STOK$1.54B

Enterprise Value

KLRA$1.37B

STOK$1.43B

Price

KLRA$11.61

STOK$24.74

P/E Ratio

KLRAN/A

STOKN/A

P/S Ratio

KLRA0.00x

STOK55.85x

EV/Sales

KLRA0.00x

STOK51.86x

EV/EBITDA

KLRA0.00x

STOK53.69x

P/B Ratio

KLRA1.20x

STOK4.78x

P/FCF Ratio

KLRAN/A

STOKN/A

EV/FCF

KLRA0.00x

STOK-7.92x

PEG Ratio

KLRAN/A

STOKN/A

Forward P/E (NTM)

KLRAN/A

STOKN/A

Forward P/S (NTM)

KLRAN/A

STOK47.27x

Revenue (TTM)

KLRA$0

STOK$28M

Revenue Growth (YoY)

KLRAN/A

STOK-86.2%

Forward Rev Growth

KLRA275.8%

STOK62.9%

Gross Margin (TTM)

KLRA0.0%

STOK0.0%

Operating Margin (TTM)

KLRA0.0%

STOK0.0%

EBITDA Margin (TTM)

KLRA0.0%

STOK-803.4%

Net Margin (TTM)

KLRA0.0%

STOK-753.6%

FCF Margin (TTM)

KLRAN/A

STOK-654.9%

Net Income (TTM)

KLRA$-190M

STOK$-208M

FCF (TTM)

KLRA$0

STOK$-181M

EPS (TTM)

KLRA-$1.86

STOK-$3.15

ROE (TTM)

KLRA0.0%

STOK-5936.0%

ROA (TTM)

KLRA0.0%

STOK-5146.0%

ROIC (TTM)

KLRA0.0%

STOK-5936.0%

Cash

KLRA$130M

STOK$110M

Debt

KLRA$0

STOK$0

Net Cash/Debt

KLRA$130M

STOK$110M

Current Ratio (TTM)

KLRA11.11x

STOK7.69x

Quick Ratio (TTM)

KLRA11.04x

STOK7.34x

Debt/Equity (TTM)

KLRA0.00x

STOK0.00x

Debt/Assets (TTM)

KLRA0.0%

STOK0.0%

Interest Coverage (TTM)

KLRAN/A

STOKN/A

Net Debt/EBITDA (TTM)

KLRA0.00x

STOK0.00x

Beta

KLRA2.22

STOK1.36

52W Performance

KLRA-55.3%

STOK-18.9%

YTD Performance

KLRA-55.3%

STOK-19.9%

% from 52W High

KLRA-58.9%

STOK-38.5%

% from 52W Low

KLRA19.0%

STOK21.8%

Asset Turnover (TTM)

KLRA0.00x

STOK0.07x

FCF Yield (TTM)

KLRA0.0%

STOK-11.7%

Earnings Yield (TTM)

KLRA-12.6%

STOK-13.5%

Dividend Yield (TTM)

KLRAN/A

STOKN/A

Rule of 40

KLRA0.0

STOK-741.1

EV/GP/RG

KLRAN/A

STOKN/A

Ticker research

View KLRA research View STOK research

Metric	KLRA Kailera Therapeutics Inc	STOK Stoke Therapeutics Inc
Market & Valuation
Market Cap	$1.50B	$1.54B
Enterprise Value	$1.37B	$1.43B
Price	$11.61	$24.74
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	55.85x
EV/Sales	0.00x	51.86x
EV/EBITDA	0.00x	53.69x
P/B Ratio	1.20x	4.78x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-7.92x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	47.27x
Revenue & Growth
Revenue (TTM)	$0	$28M
Revenue Growth (YoY)	N/A	-86.2%
Forward Rev Growth	275.8%	62.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-803.4%
Net Margin (TTM)	0.0%	-753.6%
FCF Margin (TTM)	N/A	-654.9%
Net Income (TTM)	$-190M	$-208M
FCF (TTM)	$0	$-181M
EPS (TTM)	-$1.86	-$3.15
ROE (TTM)	0.0%	-5936.0%
ROA (TTM)	0.0%	-5146.0%
ROIC (TTM)	0.0%	-5936.0%
Financial Health
Cash	$130M	$110M
Debt	$0	$0
Net Cash/Debt	$130M	$110M
Current Ratio (TTM)	11.11x	7.69x
Quick Ratio (TTM)	11.04x	7.34x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.22	1.36
52W Performance	-55.3%	-18.9%
YTD Performance	-55.3%	-19.9%
% from 52W High	-58.9%	-38.5%
% from 52W Low	19.0%	21.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.07x
FCF Yield (TTM)	0.0%	-11.7%
Earnings Yield (TTM)	-12.6%	-13.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-741.1
EV/GP/RG	N/A	N/A
Ticker research	View KLRA research	View STOK research